Following the initial impact of the COVID-19 pandemic, the European cardiac assist device market will grow moderately over the forecast period, driven by strong sales in the VAD market; new device launches in the pVAD segment in particular will fuel rapid adoption of temporary VADs.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for cardiac assist devices in Europe across a 10-year period.
The introduction of MDR in Europe will result in more stringent regulatory requirements.
What changes under the MDR will affect the cardiac assist device market?
How will this impact small and mid-sized emerging companies in the cardiac assist device market?
The VAD market will be the key driver of the overall cardiac assist device market.
Which type of VAD will be more rapidly adopted and generate the most revenue through 2028?
Is the shift from open surgery to percutaneous VADs is moving completely in the various European countries? Why?
What are the specific limiters for the VAD market in the various European countries?
The TAH market will see the strongest growth through 2028.
What are the major barriers to TAH adoption, and how will this change going forward?
What the current drawbacks associated with TAHs, and what is being done to remedy these issues?
IABPs were widely used in Europe for the treatment of AHF in 2019.
What factors have led to the substantial usage of IABPs in AHF cases?
What is limiting the market for IABPs in Germany? Why?
How will the adoption of temporary VADs affect the IABP system market through 2028?
The cardiac assist device market will be affected by the COVID-19 crisis.
How will the COVID-19 outbreak affect the cardiac assist device market?
Which market segments will be the most impacted in 2020, and why?
- Cardiac Assist Devices - Market Insights - Europe
Author(s): Siva Kumar Pulla, MBA (Pharm)
Siva Kumar Pulla is a market expert specializing in aortic repair devices within the Cardiovascular Medtech Insights team at Decision Resources Group. Siva holds a Bachelor's degree in Pharmaceutical Sciences from Jawaharlal Nehru Technological University and an MBA in Pharmaceutical Marketing from the National Institute of Pharmaceutical Education and Research, Hyderabad.